Skip to main content
Premium Trial:

Request an Annual Quote

SuperArray Inks Microarray Deal with Eurogentec

NEW YORK, Nov. 22 (GenomeWeb News) - SuperArray Bioscience today said that its cDNA GEArray-focused DNA microarray platform will be used by Eurogentec for product development.


Under the terms of the deal, Eurogentec may purchase cDNA microarray and accessory kit inventory from SuperArray under a regionally exclusive OEM agreement, SuperArray said.

Eurogentec may repackage the raw material as a unique Eurogentec product and then independently promote, market, sell, and distribute the product to its customer base in the European Union.


Additional terms of the deal were not disclosed.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.